Drug name - Zingo
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8540665 | POWDER PHARMS | Particle cassettes and processes therefor |
Oct, 2029
(7 years from now) | |
| US9358338 | POWDER PHARMS | Particle cassettes and processes therefor |
Apr, 2035
(12 years from now) | |
| US9370622 | POWDER PHARMS | Devices and methods for delivering particles |
Sep, 2035
(12 years from now) | |
Drugs and Companies using LIDOCAINE HYDROCHLORIDE ingredient
Treatment: Zingo intradermal injection system is a drug delivery system that is capable of delivering fine dry powdered lidocaine hydrochloride monohydrate for local anesthetic action; Zingo is a powder intradermal system that is capable of delivering fine dry powdered lidocaine hydrochloride monohydrate for local anesthetic action
Dosage: SYSTEM;INTRADERMAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.5MG | SYSTEM;INTRADERMAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.